Sutro Biopharma Cash from Financing (TTM) Analysis

Sutro Biopharma Inc (STRO)

4.185 +0.30 (+7.58%) USD | NASDAQ | May 07, 11:12

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	137.55M
September 30, 2023	152.90M
June 30, 2023	188.49M
March 31, 2023	56.31M
December 31, 2022	48.31M
September 30, 2022	36.60M
June 30, 2022	7.714M
March 31, 2022	2.19M
December 31, 2021	3.256M
September 30, 2021	147.60M
June 30, 2021	163.91M

Date	Value
March 31, 2021	255.37M
December 31, 2020	269.25M
September 30, 2020	122.61M
June 30, 2020	104.21M
March 31, 2020	11.98M
December 31, 2019	-4.184M
September 30, 2019	85.45M
June 30, 2019	136.75M
March 31, 2019	170.34M
December 31, 2018	170.78M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-4.184M

Minimum

Dec 2019

269.25M

Maximum

Dec 2020

101.38M

Average

104.21M

Median

Jun 2020

Cash from Financing (TTM) Benchmarks